October 3, 2016 / 12:22 PM / 10 months ago

BRIEF-AnaptysBio reports ANB020 top-line early-stage clinical trial results

1 Min Read

Oct 3 (Reuters) - AnaptysBio Inc

* Reports ANB020 Top-Line phase 1 clinical trial results

* Reports ANB020 top-line phase 1 clinical trial results; favorable safety and pharmacodynamic parameters demonstrated in healthy volunteers

* US IND and UK CTA filings submitted to enable multiple phase 2 trials Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below